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Abstract
Background: Transthoracic echocardiography (TTE) is routinely used to calculate aortic valve area (AVA) by continuity 
equation (CE). However, accurate measurement of the left ventricular outflow tract (LVOT) can be difficult and flow 
acceleration in the LVOT may lead to miscalculation of the AVA. 
Objective: The aim of our study was to compare AVA measurements by standard TTE, cardiac magnetic resonance 
imaging (MRI) and a hybrid approach combining both techniques.
Methods: AVA was calculated in 38 patients (age 73±9 years) with standard TTE, cine-MRI planimetry and a hybrid 
approach: Hybrid Method 1: TTE-derived LVOT measurement in the CE numerator was replaced by the MRI assessment 
of the LVOT and AVA was calculated: (LVOTMRI/*LVOT-VTITTE)/transaortic-VTITTE. Method 2: We replaced the SV in the 
numerator by the MRI-derived SV and calculated AVA = SVMRI/ transaortic-VTITTE.
Results: Mean AVA derived by TTE was 0.86 cm2±0.23 cm2 and 0.83 cm2±0.3 cm2 by MRI- planimetry, respectively. The 
mean absolute difference in AVA was 0.03cm2 for TTE vs. MRI planimetry. AVA calculated with method 1 and method 2 
was 1.23 cm2±0.4cm2 and 0.92cm2±0.32cm2, respectively. The mean absolute difference between TTE and method 1 
and method 2 was 0.37cm2 and 0.06cm2, respectively (p<0.001). 
Conclusion: MRI-planimetry of AVA and hybrid method 2 are accurate and showed a good agreement with standard 
TTE measurements. Therefore, hybrid method 2 is a reasonable alternative if poor acoustic windows or LVOT flow 
accelerations limit the accuracy of TTE, particularly in patients at high risk for an invasive hemodynamic study. (Arq Bras 
Cardiol 2012;98(3):234-242)
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Nevertheless, doppler-derived calculation of AVA using 
the continuity equation (CE) can be difficult, due to poor 
echocardiographic conditions such as a limited acoustic window, 
heavy calcifications of the aortic valve or flow acceleration in 
the LVOT due to a septal bulge, a common finding in AS. When 
these factors question a proper orifice area quantification, we 
have to rely on alternative methods including transesophageal 
planimetry of the AVA, replacing the Doppler-derived stroke 
volume (SV) in the CE by SV measured Swan-Ganz Catheter 
or invasive quantification by cardiac catheterization and 
applying the Gorlin formula3. However, the invasive nature 
and the increased stroke risk4 with retrograde catheterisation 
of the aortic valve (AV) limits its clinical use. Hence, there is 
still a need for an alternative approach to the standard CE 
and invasive procedures in selected patients. Cardiovascular 
magnetic resonance imaging (MRI) is an important non-invasive 
tool for the diagnosis and treatment evaluations of patients with 
cardiovascular disease. Measurements of both blood flow and 
flow volume qualify MRI as an ideal technique for the evaluation 
of cardiac function and volumes. Therefore, the purpose of 
our study was to compare AVA measurements by standard 
TTE, cardiac magnetic resonance imaging (MRI) and a hybrid 
approach combining both techniques.
Introduction 
Therapeutic decisions in aortic stenosis (AS) are based 
on disease-specific symptoms and on hemodynamic 
severity, measured by using the aortic valve area (AVA). 
Thus, an accurate evaluation of these two issues is 
mandatory. Transthoracic echocardiogram (TTE) with 
Doppler interrogation of the aortic valve serves as the 
mainstay of diagnosis1,2. The parameters referred to in 
current guidelines1 for grading the severity of AS are the 
AVA ≤ 1cm2, mean pressure gradient ≥ 40mmHg (Pmean) 
and peak flow velocity ≥ 400cm/s (Vmax). In patients 
with normal left ventricular ejection fraction (EF), these 
parameters should allow a dependable classification of the 
severity of AS as mild, moderate or severe. In clinical practise, 
a good TTE study can provide all the parameters necessary 
to assess the severity of stenosis. 
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Methods
Patients
A cohort of 38 consecutive patients referred to the 
Department of Cardiology with a diagnosis of moderate to 
severe AS was recruited into the study. The study protocol was 
approved by the regional ethics committee. Exclusion criteria 
were concomitant mitral valve disease, severe low gradient 
AS, EF < 35%, hypertrophic obstructive  cardiomyopathy, 
uncontrolled hypertension, severe arrhythmias, and general 
exclusion criteria for MRI. 
Transthoracic Echocardiography
All patients underwent transthoracic echocardiography 
using standard 2-D, CW-, PW-and colour Doppler techniques 
(Vingmed Vivid 7, General Electric, Milwaukee, Wisconsin). 
LV EF was quantified according to the Simpson method. LV 
dimensions and left ventricular muscle mass (LVM) were 
measured in the parasternal long axis view according to 
the American Society of Echocardiography guidelines2 and 
indexed for body surface area (BSA). Doppler assessment 
of AS included measurement of Pmean, Pmax and 
Vmax. AVA was calculated by means of the CE (AVA = 
([LVOTdiameter/2])
2*π*[LVOT-VTI/transaortic-VTI) and indexed 
for body surface area. The pressure recovery adjusted aortic 
valve area (i.e. energy loss index (ELI)) was calculated by a 
previously validated formula5. Severe AS was defined as 
AVA < 1 cm2 with a Pmean ≥ 40mmHg. Tissue Doppler 
velocity imaging and 2D strain analysis were performed as 
previously described6.
Magnetic resonance imaging
A 1.5-T Achieva MRI scanner (Philips Medical Systems, 
Netherlands) equipped with a 5-element cardiac synergy 
coil was used. Cine-Images were acquired in breath hold 
SSFP sequences (TE 3.43, TR 1.72). Images were evaluated 
with the cmr42 research edition toolkit (circle cardiovascular 
imaging, Calgary, Canada) combining long and short axis 
views. Non-myocardial structures and papillary muscles 
were carefully excluded and endocardial as well as epicardial 
borders were outlined manually. Endsystolic and enddiastolic 
volumes were calculated by the program software. AVA 
planimetry was performed in the cardiac phase where the 
maximal opening area of the leaflets was observed. A three-
chamber view and LVOT view were performed with cine 
imaging using fast-field echo sequence. The planimetric area 
of the LVOT cross sectional area (LVOTCSA) was measured 
mid-systolic. Additionally, the diameter of the LVOT was 
measured in the three-chamber view (as normally done with 
TTE), and the LVOT area was calculated according to LVOTCSA 
= (LVOTdiameter /2)
2*π. MRI velocity measurements in phase 
contrast technique of the aortic valve and the LVOT were 
performed as described before7. 
Hybrid approach
Method 1: The LVOTCSA value determined by 2D 
echocardiography in the CE numerator was replaced by the 
MRI planimetry of LVOT and calculated AVA = (LVOTCSA 
MRI*LVOT-VTI Echo)/transaortic-VTI Echo. 
Method 2: The CE numerator (stroke volume, SV) 
was determined by MRI and the denominator (velocity 
time integral through the aortic valve) was measured by 
echocardiography. We calculated AVA = SV MRI/ transaortic-
VTI (echocardiography).
Statistics
All analyses were performed using SPSS statistical software 
(SPSS 17.0, Chicago, IL). The data are presented as mean ± SD 
unless otherwise specified. A p value < 0.05 was considered 
statistically significant and adjusted for multiple comparisons 
using Bonferroni adjustment. Comparison between two or 
more groups was assessed by one-way analysis of variance 
(ANOVA) or t- Test when appropriate.
When normality and/or equal variance testing conditions 
were not met, the Kruskal-Wallis rank test was used. Pearson’s 
linear correlation coefficients were calculated for continuous 
variables. Stepwise multiple variable regression models 




A total number of 38 patients with moderate to severe AS 
(16 women, 22 men, mean age 73±9 years) were included in 
the study. Baseline demographics, clinical characteristics and 
key echocardiographic and MRI measurements are highlighted 
in table 1a. Concomitant coronary artery disease (CAD) was 
present in 66% of patients. 
Echocardiography
According to the AVA, 26 (68%) patients were classified as 
having severe aortic stenosis (AVAindex < 1.0 cm2) and 12 
individuals (32%) were classified as moderate AS, respectively. 
The AVA ranged 0.43-1.35 cm2 (mean 0.86±0.23 cm2, mean 
AVAindex 0.47±0.12cm2/m2, table 1b). The mean pressure 
gradient was 45±18mmHg, and Vmax was 434±71cm/s. 
Mean left ventricular ejection fraction (EF) was 64±12%. The 
LVOTCSA ranged from 3.1-4.9cm
2 (mean 3.62±0.62cm2) and 
the LVOT diameter from 2.0-2.5cm (mean 2.14±0.1818cm2). 
The mean stroke volume (SV) was 80±15ml/beat, respectively. 
Magnetic resonance imaging
All examinations were diagnostic and well-tolerated by 
the patients. No complications occurred during any of the 
investigations. MRI allowed the planimetry of the AVA and 
LVOTCSA as well as measuring the diameter of LVOT in 35 
individuals. Mean heart rate was 65±14 beats/min. Mean 
AVA measured by planimetry was 0.82±0.3cm2 (AVAindex 
0.46±0.16cm/m2), while the planimetry of the LVOTCSA 
ranged from 3.0-7.5cm2 (mean 5.01±1.08 cm2). Mean 
LVOT diameter measured in the three-chamber view was 
2.36±0.47cm, and the LVOTCSA calculated from the LVOT 
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diameter was 4.45±1.63cm2, respectively. Mean SV was 
86±22ml/beat.
Table 2 shows a comparison between echocardiographic 
and MRI measurement. The LVOTCSA calculated from the 
LVOT diameter with MRI techniques was significantly 
different compared to the standard echocardiographic 
determinat ion of  the LVOTCSA (mean d i f fe rence 
0.94cm2±1.54cm2, CI 0.43-1.45, p=0,001). Likewise, the 
results from LVOT diameter measurement with MRI or TTE 
techniques were significantly different (mean difference 
0.22±0.45cm, CI 0.07-0.37, p=0.04). In addition, the 
planimetry of the LVOTCSA using MRI reveals significantly 
larger LVOTCSA in comparison to TTE determination (mean 
difference 1.39±0.88cm2, CI 1.09-1.67, p<0.001). Stroke 
volume measurements based on MRI and TTE showed a 
moderate correlation (r=0.56, p<0.001, mean difference 
6.8±18.6ml/b, CI 0.7-12.9, p = 0.03). 
Comparing the hybrid approach with standard continuity 
equation
Results for calculation of AVA are summarized in Table 3. 
There was no statistically significant difference for mean 
Table 1 - a) Demographics and clinical data b) Echocardiographic and MRI measurements in individuals with aortic valve stenosis summarized
Demographics
Variable n = 38
Echocardiography/MRI
Variable n = 38
Age (mean ±SD) 73±9 Vmax (cm/s) 434±71
Woman (n / %) 16/42 Pmax (mmHg) 77±26
CAD (n / %) 25/66 Pmean (mmHg) 45±18
Hx of MI (n / %) 4/10 AVA (cm2) 0.86±0.23
Hx of CABG (n / %) 2/5 AVA index (cm2/m2  BSA) 0.47±0.12
Diabetes mellitus (n / %)  13/34 ELI (cm2/m2 BSA. mean ± SD) 0.54±0.16
Hypertension (n / %) 33/87 E/A 1.1±0.8
Hyperlipidemia (n / %) 20/53 Smax (cm/s) 4.8±1.3
Smoking (n / %) 6/16 E´ (cm/s) 4.5±1.2
ACE-inhibitor (n / %) 26/66 E/E´ (mean ± SD) 20.5±8.6
ß-Blockers (n / %) 29/76 CO (Echo. l/min) 5.0±2.1
Statins (n / %) 19/50 SV (MRI. ml/beat) 86±22
CRP (mg/dl) 0.94 SV (Echo. ml/beat) 80±15
Hemoglobin (g/dl) 13.3±1.6 EF (Echo. %) 64±12
Creatinine (mg/dl) 1.08 EF (MRI. %) 68±28
Blood pressure (mmHg) 143/77 LVM (Echo. g/m2 BSA) 121±36
Euroscore (%) 11.1 GLS Baseline (%) -15.2±3.6
Euroscore additive 7.1± 0.3 Aortic root (mm) 31±3.1
NYHA 2.61±0.97 LVOT diameter (MRI. cm) 2.4±0.5
NT-proBNP (pg/ml) 2939±4211 LVOT diameter (Echo. cm) 2.1±0.18
CAD - coronary artery disease; Hx - history of; LVM - left ventricular muscle mass index; MI - myocardial infarction; SD - standard deviation; AVA - aortic valve area; 
AVR - aortic valve replacement; BSA - body surface area; CO - cardiac output; ELI - energy loss index; EF - ejection fraction; GLS - global longitudinal strain; LVOT - left 
ventricular outflow tract; LVM - left ventricular mass index; MRI - magnetic resonance imaging; Smax - peak systolic tissue doppler velocity at the septal mitral annulus; 
SV - stroke volume; Continues variables are presented as mean ± SD.
Table 2 - Comparison of LVOT measurement with TTE and MRI





TTE (mean ± SD. cm) 2.14 ± 0.18* 3.62 ± 0.62#.+ -
MRI (mean ± SD. cm2) 2.36 ± 0.47* 4.45 ± 1.63# 5.01 ± 1.08+
p-value *0.004 #0.001 +<0.001
CSA - cross sectional area; TTE - transthoracic echocardiography; MRI - magnetic resonance imaging; LVOT - left ventricular outflow tract; SD - standard deviation.
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indexed AVA between standard CE and hybrid method 2 
(mean difference 0.03±0.11cm2/m2, CI = -0.007-0.069, 
p = 0.11) and between standard CE and MRI planimetry 
of the AVA (mean difference 0.04±0.15cm2/m2, CI -0.09-
0.012, p = 0.14). On the contrary, AVA measurements by 
hybrid approach 1 and standard CE revealed a significant 
difference (mean difference 0.21±0.14cm2/m2, CI -0.17-
0.25, p < 0.001, Fig. 1). Correlation between standard CE 
and the hybrid techniques were significant (indexed AVA) 
for the hybrid method 1, 2 and AVA planimetry (p<0,001, 
figure. 2a-c), respectively. Bland-Altman plots are shown 
in Figure 3 a-c. Table 4 illustrates the frequency of the 
severity of AS by the different techniques categorized into 
mild, moderate and severe. 
The correlation between standard CE and hybrid 
techniques for the non-indexed AVA was also significant for 
the hybrid method 1, 2 and AVA planimetry (r = 0.556, r = 
0.800 and r = 0.710 respectively, all p < 0.001).
Discussion 
In individuals with severe aortic stenosis, a modified continuity 
equation combining MRI and echocardiography revealed a very 
good agreement compared to standard continuity equation. The 
comparison of both hybrid method 2 and MRI planimetry of the 
AVA to standard TTE by Bland Altman analysis showed a mean 
difference near zero, a spread within two standard deviations 
(SD) and very similar limits of agreement. Furthermore, the vast 
Table 3 - Results for calculation of AVA based on standard CE (TTE) and the hybrid approach







AVA (cm2) 0.86±0.23 1.23±0.41 0.92±0.32 0.83±0.30
AVAindex (cm2/m2) 0.47±0.12*1,2,3 0.68±0.21*1 0.50±0.16*2 0.46±0.16*3
p-value - *1<0.001+ *2=0.11 n.s. *3=0.14 n.s.





AVA index standard CE AVA index hybrid 2 AVA index hybrid 1 AVAindex planimetry
Figure 1 - Indexed aortic valve area (cm2/m2) determined by standard continuity equation and hybrid techniques; Hybrid method 1 reveals significant larger aortic valve 
areas indexed for body surface area (AVA index) compared to standard continuity equation based on echocardiography. There was no significant difference between 
standard echocardiography assessment of AVA index and hybrid method 2 and AVA planimetry, respectively. AVA - Aortic valve area
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majority of patients (92%) were classified as having severe 
AS with standard CE, hybrid method 2 and AVA planimetry. 
Since the ability to identify individuals with definite severe 
AS may have therapeutic implications; these findings are 
of great importance. 
Calculation of AVA by means of Doppler echocardiography 
is a widely used standard for evaluation of aortic valve 
stenosis in clinical practice. Transthoracic echocardiography 
(TTE) plays an important role in management decisions 
including indications for surgery and scheduling follow-
ups in individuals with AS. TTE is non invasive, easily to 
perform, readily available and inexpensive and offers an 
acceptable intraobserver and interobserver reproducibility. 
Therefore, a full hemodynamic study with retrograde 
catheterisation of the AV is no longer recommended if 
non invasive assessment of the severity of AS is adequate 
to assess valve hemodynamics.
Echocardiographic valve area calculation is based on 
the CE, which assumes that the flow (F) on both sides of 
the aortic valve orifice is equal3. Flow is defined as cross 
sectional area (CSA) multiplied by flow velocity (V). Across 
the aortic valve (AV), the flow is equal to stroke volume 
(SV). Because SV is the product of the CSA and time velocity 
integral (VTI), the CE can be arranged to yield: AVA = 
(LVOTVTI x LVOTCSA)/AVVTI), in which LVOTVTI is the velocity 
time integral at the level of the stenotic valve and CSA is 
the cross sectional area of the LVOT. 
In most echocardiographic studies, reproducibility of LVOT 
measurement is sufficient. Nevertheless, significant variability 
can occur8. Potential factors that may contribute to measurement 
errors include image quality, annular calcifications, a noncircular 
annulus and general failure in measuring the actual area. 
LVOT diameter measurement is squared; therefore any 
significant LVOT diameter measurement error will also be 
squared, producing a potentially unacceptable error in the 
AVA calculation. Accordingly, accurate measurement of the 
LVOT is critical. Previous studies have shown that the mean 
interobserver und intraobserver measurement variability is 5% 
to 8%, resulting in a variability of calculated valve area of about 
0.15cm2 for a borderline AS with an AVA of 1cm2. Furthermore, 
flow acceleration in the LVOT may lead to overestimation of 










AVA Echocardiography (cm2/m2) AVA Echocardiography (cm2/m2)
Figure 2 - Correlation of standard AVA index measurement and hybrid approach 1(a), 2(b) and MRI planimetry (c) 
Figure 2a - Linear regression analysis demonstrates a significant correlation between AVA-index (cm2/m2 BSA) derived by standard CE (TTE) and hybrid method 1. 
Figure 2b - Linear regression analysis demonstrates a significant correlation between AVA-index (cm2/m2 BSA) derived by standard CE (TTE) and hybrid method 2. 
Figure 2c - Linear regression analysis demonstrates a significant correlation between AVA-index (cm2/m2 BSA) derived by standard CE (TTE) and MRI planimetry. 
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the AVA. Hence, assessing the severity of AS is not always 
straightly apparent.
When  echoca rd iog raph ic  measu rement s  a re 
inconsistent, invasive hemodynamic remain the gold 
standard. However, aortic atheroma is a common 
finding in individuals with AS and is a potential source of 
ischaemic stroke, especially during cardiac catheterisation 
or surgery4. Therefore, a non-invasive alternative 
particularly in patients at high risk of procedure-associated 
complications is needed.
Table 4 - Frequency of the severity of AS by 4 different imaging techniques
Classification TTE Hybrid Method 1 Hybrid Method 2 AVAMRI planimetry
Mild (> 1.5cm2) - 26% 3% -
moderate (1.0-1.5cm2) 34% 40% 34% 32%
Severe (< 1.0cm2) 66% 34% 63% 68%
Values are presented as percent. Aortic stenosis is categorized as mild, moderate and severe based on aortic valve area (cm2); AVA - Aortic valve area; TTE - transthoracic 















AVA index (planimetry – TTE)/2
Figure 3 - Bland-Altman analyses illustrating the agreement between standard AVA-assessment and hybrid-approach 1(a), 2(b) and MRI planimetry(c). 
Figure 3a - Agreement between AVA measured by standard CE (TTE) indexed for BSA (cm2/m2) and hybrid method 1. The continuous line represents the mean 
difference, and the dashed lines represent limits of agreement. 
Figure 3b - Agreement between AVA measured by standard CE (TTE) indexed for BSA (cm2/m2) and hybrid method 2. The continueous line represents the mean 
difference, and the dashed lines represent limits of agreement. 
Figure 3c - Agreement between AVA measured by standard CE (TTE) indexed for BSA (cm2/m2) and MRI planimetry of the AVE. The continuous line represents the 
mean difference, and the dashed lines represent limits of agreement. 
AVA - Aortic valve area; BSA - Body surface area; CE - continuity equation; TTE - transthoracic echocardiography. 
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Our results demonstrate that the standard CE can be 
modified when necessary: the modification is simple and 
merely consists of replacing the Doppler-derived stroke volume 
by a MRI determination of stroke volume (hybrid method 2). 
Previous studies have demonstrated MRI as a very useful tool for 
evaluation of ventricular flow as it is independent of geometric 
assumptions, as well as accurate and reproducible9. On the 
contrary, the echocardiographic simplified Bernoulli equation 
ignores the flow acceleration proximal to the stenosis, which is an 
acceptable assumption as long as the transvalvular flow velocity 
is significantly greater than the proximal flow velocity. However, 
in the presence of accelerated flow or less significant stenosis, 
the simplified Bernoulli equation is less accurate. 
Flow acceleration in the LVOT can affect AVA calculation 
by overestimating the actual AVA10. By contrast, SV calculation 
by MRI is not affected by flow acceleration in the LVOT. 
Therefore, replacing the SV in the CE by MRI derived SV 
measurement may be more accurate in situations where 
significant flow acceleration is present in the LVOT. On the other 
hand, Doppler-derived gradients correlate well with invasively 
measured pressure gradients as it has been demonstrated in 
the experimental and in the clinical setting11,12. Therefore, 
combining measurements of SV by MRI with measurements 
of VTI across the aortic valve by echocardiography in hybrid 
approach 2 takes advantages of both methods. It yields results 
with very small differences compared to standard CE and 
accurately identifies the vast majority of severe AS. Using a 
hybrid approach bypasses the need for accurate measurement 
of the LVOT diameter and LVOT flow and therefore may be an 
acceptable alternative when measuring the LVOT is not possible.
Furthermore, planimetric-derived AVA by MRI is accurate 
and correlates well with the one obtained by echocardiography. 
These findings are congruent with the literature published 
concerning this matter13.  Although attractive, direct planimetry 
of the AVA by MRI is nonetheless a technically demanding 
method. It requires precise measurement at the valve tips during 
their maximal opening. This can be challenging as there may be 
heavy calcifications of the tips leading to image artefacts, and 
a precise view of the aortic valve leaflets, since partial volume 
effects may be difficult. In addition, MRI planimetry represents 
a single time point measurement of AVA at maximal systole, 
while CE is measured as average over the whole ejection 
period. The AVA, however, may vary substantially during the 
ejection period14. 
In contrast to planimetry and hybrid method 2, hybrid 
method 1 failed to demonstrate a good agreement compared 
to standard CE. The MRI images in our study reveal that the 
LVOT geometry resembles a more elliptical rather than a 
circular shape and therefore a larger LVOTCSA was determined. 
Replacing the LVOTCSA measurement in the standard CE with 
MRI planimetry of the LVOT, it remains doubtful whether 
the standard CE permits an accurate calculation of the AVA, 
because standard CE assumes a circular shape of the LVOTCSA. 
Accordingly, whether LVOT is obtained with echocardiography 
or MRI, these two approaches cannot be used interchangeably.
In general, despite the fact that MRI overcomes some 
of the methodological limitations of echocardiography 
mentioned above, it seems unlikely for MRI to replace TTE 
as the image modality of first choice in evaluating individuals 
with aortic stenosis. However, our data are consistent with 
previously published studies, suggesting that a hybrid approach 
combining TTE and MRI as a promising alternative diagnostic 
tool for evaluating the severity of AS noninvasively when 
echocardiography is inconclusive. 
Limitations
The cohort of 38 individuals included in this pilot 
study is relatively small and does not allow performing a 
subgroup analysis. Therefore, we must remain cautious in 
the interpretation of these data considering the relatively 
small number of patients. However, these preliminary 
results encouraged us to investigate this issue in a larger 
study group.
Furthermore, only a small proportion of patients had 
invasive measurement of AVA by cardiac catheterization. 
Therefore, the results comparing standard CE and the 
hybrid approach should be analysed with caution because 
the “gold standard” in determining the severity of AS is 
not available, therefore new methods should be judged. 
Nevertheless, invasive measurement of AS is based on 
the “Gorlin formula” which has many well-recognized 
limitations15, whereas the continuity equation method for 
calculation of AVA has the advantage of being non-invasive 
and of not containing an empirical constant16.
Another limitation of our study was a well preserved EF in 
most patients included in the study (64 ± 12%). However, 
especially in patients with severely impaired EF (low flow, 
low gradient aortic stenosis), the accurate assessment of 
AVA using Doppler TTE is challenged by the limitations of 
Doppler flow parameters17. 
Conclusions 
The calculation of AVA by a non-invasive hybrid approach 
between echocardiography and MRI is a good alternative to 
standard CE and correlates well with the standard method. 
The hybrid approach is more time consuming, not widely 
available and more cost intensive than standard CE and 
will certainly not replace TTE in clinical routine. However, 
this method could be used as a non-invasive alternative in 
patients in whom echocardiographic results are inconclusive 
or in whom conflicting results require further clarifications, 
particularly in patients with a high risk for an invasive 
hemodynamic study.
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